Prehospital Interventions to Improve Neurological Outcome Following Cardiac Arrest

ABSTRACT

As many cases of cardiac arrest occur outside of the health care setting, prehospital treatment may dramatically affect patient outcomes. The three major interventions that have been studied are chest compressions and ventilation, electrical defibrillation, and medications. Recent studies show that increasing the rate of cardiopulmonary resuscitation (CPR), decreasing the rate of ventilation, and initiation of CPR prior to defibrillation may result in improved survival. Biphasic defibrillators can restore perfusing rhythms while minimizing myocardial injury. Public access to automatic defibrillators has been shown to increase the survival of cardiac arrest patients. Medications such as amiodarone, vasopressin, and thrombolytics also may have a role in the prehospital treatment of cardiac arrest. Recent advances in these areas will be reviewed with a discussion of the effect of each intervention on the restoration of circulation and neurological outcomes.

Cardiac arrest - prehospital treatments - neuroprotection

REFERENCES

• 1 Eisenberg M S, Mengert T J. Cardiac resuscitation.  N Engl J Med. 2001;  344 1304-1313
• 2 Weisfeldt M L, Becker L B. Resuscitation after cardiac arrest: a 3-phase time-sensitive model.  JAMA. 2002;  288 3035-3038
• 3 Paradis N A, Martin G B, Rivers E P et al.. Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation.  JAMA. 1990;  263 1106-1113
• 4 Gazmuri R J, von Planta M, Weil M H et al.. Arterial PCO2 as an indicator of systemic perfusion during cardiopulmonary resuscitation.  Crit Care Med. 1989;  17 237-240
• 5 Michael J R, Guerci A D, Koehler R C et al.. Mechanisms by which epinephrine augments cerebral and myocardial perfusion during cardiopulmonary resuscitation in dogs.  Circulation. 1984;  69 822-835
• 6 Lee S K, Vaagenes P, Safar P et al.. Effect of cardiac arrest time on cortical cerebral blood flow during subsequent standard external cardiopulmonary resuscitation in rabbits.  Resuscitation. 1989;  17 105-117
• 7 Berkowitz I D, Gervais H, Schleien C L et al.. Epinephrine dosage effects on cerebral and myocardial blood flow in an infant swine model of cardiopulmonary resuscitation.  Anesthesiology. 1991;  75 1041-1050
• 8 Paradis N A, Martin G B, Goetting M G et al.. Simultaneous aortic, jugular bulb, and right atrial pressures during cardiopulmonary resuscitation in humans: insights into mechanisms.  Circulation. 1989;  80 361-368
• 9 Chen Y S, Chao A, Yu H Y et al.. Analysis and results of prolonged resuscitation in cardiac arrest patients rescued by extracorporeal membrane oxygenation.  J Am Coll Cardiol. 2003;  41 197-203
• 10 American Heart Association in collaboration with International Liaison Committee on Resuscitation . Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: International Consensus on Science, Part 6: Advanced Cardiovascular Life Support: 7B: Understanding the Algorithm Approach to ACLS.  Circulation. 2000;  102(suppl I) I140-I141
• 11 Kern K B, Hilwig R W, Berg R A et al.. Importance of continuous chest compressions during cardiopulmonary resuscitation: improved outcome during a simulated single lay-rescuer scenario.  Circulation. 2002;  105 645-649
• 12 Berg R A, Kern K B, Hilwig R W et al.. Assisted ventilation does not improve outcome in a porcine model of single-rescuer bystander cardiopulmonary resuscitation.  Circulation. 1997;  95 1635-1641
• 13 Aufderheide T P, Lurie K G. Death by hyperventilation: a common and life-threatening problem during cardiopulmonary resuscitation.  Crit Care Med. 2004;  32 S345-S351
• 14 Adams C P, Martin G B, Rivers E P et al.. Hemodynamics of interposed abdominal compression during human cardiopulmonary resuscitation.  Acad Emerg Med. 1994;  1 498-502
• 15 Lindner K H, Pfenninger E G, Lurie K G et al.. Effects of active compression-decompression resuscitation on myocardial and cerebral blood flow in pigs.  Circulation. 1993;  88 1254-1263
• 16 Halperin H R, Tsitlik J E, Gelfand M et al.. A preliminary study of cardiopulmonary resuscitation by circumferential compression of the chest with use of a pneumatic vest.  N Engl J Med. 1993;  329 762-768
• 17 Aufderheide T P, Pirrallo R G, Yannopoulos D et al.. Incomplete chest wall decompression: a clinical evaluation of CPR performance by EMS personnel and assessment of alternative manual chest compression-decompression techniques.  Resuscitation. 2005;  64 353-362
• 18 Plaisance P, Lurie K G, Payen D. Inspiratory impedance during active compression-decompression cardiopulmonary resuscitation: a randomized evaluation in patients in cardiac arrest.  Circulation. 2000;  101 989-994
• 19 Adgey A A, Spence M S, Walsh S J. Theory and practice of defibrillation: (2) defibrillation for ventricular fibrillation.  Heart. 2005;  91 118-125
• 20 Cobb L A, Fahrenbruch C E, Walsh T R et al.. Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation.  JAMA. 1999;  281 1182-1188
• 21 Wik L, Hansen T B, Fylling F et al.. Delaying defibrillation to give basic cardiopulmonary resuscitation to patients with out-of-hospital ventricular fibrillation: a randomized trial.  JAMA. 2003;  289 1389-1395
• 22 Jacobs I G, Finn J C, Oxer H F et al.. CPR before defibrillation in out-of-hospital cardiac arrest: a randomized trial.  Emerg Med Australas. 2005;  17 39-45
• 23 Weisfeldt M L, Becker L B. Resuscitation after cardiac arrest: a 3-phase time-sensitive model.  JAMA. 2002;  288 3035-3038
• 24 Eisenberg M S, Copass M K, Hallstrom A P et al.. Treatment of out-of-hospital cardiac arrests with rapid defibrillation by emergency medical technicians.  N Engl J Med. 1980;  302 1379-1383
• 25 Stiell I G, Wells G A, Field B J et al.. Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: OPALS study phase II. Ontario Prehospital Advanced Life Support.  JAMA. 1999;  281 1175-1181
• 26 Stiell I G, Wells G A, Field B et al.. Advanced cardiac life support in out-of-hospital cardiac arrest.  N Engl J Med. 2004;  351 647-656
• 27 White R D, Hankins D G, Bugliosi T F. Seven years' experience with early defibrillation by police and paramedics in an emergency medical services system.  Resuscitation. 1998;  39 145-151
• 28 Page R L, Joglar J A, Kowal R C et al.. Use of automated external defibrillators by a U.S. airline.  N Engl J Med. 2000;  343 1210-1216
• 29 Valenzuela T D, Roe D J, Nichol G et al.. Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos.  N Engl J Med. 2000;  343 1206-1209
• 30 Hallstrom A P, Ornato J P, Weisfeldt M et al.. Public-access defibrillation and survival after out-of-hospital cardiac arrest.  N Engl J Med. 2004;  351 637-646
• 31 Culley L L, Rea T D, Murray J A et al.. Public access defibrillation in out-of-hospital cardiac arrest: a community-based study.  Circulation. 2004;  109 1859-1863
• 32 Vandycke C, Martens P. High dose versus standard dose epinephrine in cardiac arrest: a meta-analysis.  Resuscitation. 2000;  45 161-166
• 33 Jaffe R, Rubinshtein R, Feigenberg Z et al.. Evaluation of isoproterenol in patients undergoing resuscitation for out-of-hospital asystolic cardiac arrest (the Israel Resuscitation with Isoproterenol Study Prospective Randomized Clinical Trial).  Am J Cardiol. 2004;  93 1407-1409
• 34 Patrick W D, Freedman J, McEwen T et al.. A randomized, double-blind comparison of methoxamine and epinephrine in human cardiopulmonary arrest.  Am J Respir Crit Care Med. 1995;  152 519-523
• 35 Lindner K H, Dirks B, Strohmenger H U et al.. Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation.  Lancet. 1997;  349 535-537
• 36 Dorian P, Cass D, Schwartz B et al.. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation.  N Engl J Med. 2002;  346 884-890
• 37 Kudenchuk P J, Cobb L A, Copass M et al.. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation.  N Engl J Med. 1999;  341 871-878
• 38 Miller B, Craddock L, Hoffenberg S et al.. Pilot study of intravenous magnesium sulfate in refractory cardiac arrest: safety data and recommendations for future studies.  Resuscitation. 1995;  30 3-14
• 39 Fatovich D M, Prentice D A, Dobb G J. Magnesium in cardiac arrest (the magic trial).  Resuscitation. 1997;  35 237-241
• 40 Hassan T B, Jagger C, Barnett D B. A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation.  Emerg Med J. 2002;  19 57-62
• 41 Allegra J, Lavery R, Cody R et al.. Magnesium sulfate in the treatment of refractory ventricular fibrillation in the prehospital setting.  Resuscitation. 2001;  49 245-249
• 42 Thel M C, Armstrong A L, McNulty S E et al.. Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff.  Lancet. 1997;  350 1272-1276
• 43 Mader T J, Gibson P. Adenosine receptor antagonism in refractory asystolic cardiac arrest: results of a human pilot study.  Resuscitation. 1997;  35 3-7
• 44 Mader T J, Smithline H A, Durkin L et al.. A randomized controlled trial of intravenous aminophylline for atropine-resistant out-of-hospital asystolic cardiac arrest.  Acad Emerg Med. 2003;  10 192-197
• 45 Lederer W, Lichtenberger C, Pechlaner C et al.. Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest.  Resuscitation. 2001;  50 71-76
• 46 Bottiger B W, Bode C, Kern S et al.. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial.  Lancet. 2001;  357 1583-1585
• 47 Abu-Laban R B, Christenson J M, Innes G D et al.. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity.  N Engl J Med. 2002;  346 1522-1528
• 48 Fatovich D M, Dobb G J, Clugston R A. A pilot randomised trial of thrombolysis in cardiac arrest (The TICA trial).  Resuscitation. 2004;  61 309-313
• 49 Longstreth Jr W T, Fahrenbruch C E, Olsufka M et al.. Randomized clinical trial of magnesium, diazepam, or both after out-of-hospital cardiac arrest.  Neurology. 2002;  59 506-514
• 50 Roine R O, Kaste M, Kinnunen A et al.. Nimodipine after resuscitation from out-of-hospital ventricular fibrillation: a placebo-controlled, double-blind, randomized trial.  JAMA. 1990;  264 3171-3177
• 51 Longstreth Jr W T, Copass M K, Dennis L K et al.. Intravenous glucose after out-of-hospital cardiopulmonary arrest: a community-based randomized trial.  Neurology. 1993;  43 2534-2541
• 52 Lederer W, Lichtenberger C, Pechlaner C et al.. Long-term survival and neurological outcome of patients who received recombinant tissue plasminogen activator during out-of-hospital cardiac arrest.  Resuscitation. 2004;  61 123-129
• 53 Newman D H, Greenwald I, Callaway C W. Cardiac arrest and the role of thrombolytic agents.  Ann Emerg Med. 2000;  35 472-480